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Mild hyperlipidemia in mice 
aggravates platelet responsiveness 
in thrombus formation 
and exploration of platelet 
proteome and lipidome
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Fiorella A. Solari2, Bing Peng2, Kenneth J. Clemetson4, Richard W. Farndale5, 
Ludwig J. Dubois6, Albert Sickmann2, René P. Zahedi2,7, Robert Ahrends2,8, 
Erik A. L. Biessen3,9, Judith C. Sluimer3,10, Johan W. M. Heemskerk1 & Marijke J. E. Kuijpers1*
Hyperlipidemia is a well-established risk factor for cardiovascular diseases. Millions of people 
worldwide display mildly elevated levels of plasma lipids and cholesterol linked to diet and life-style. 
While the prothrombotic risk of severe hyperlipidemia has been established, the effects of moderate 
hyperlipidemia are less clear. Here, we studied platelet activation and arterial thrombus formation 
in Apoe−/− and Ldlr−/− mice fed a normal chow diet, resulting in mildly increased plasma cholesterol. In 
blood from both knockout mice, collagen-dependent thrombus and fibrin formation under flow were 
enhanced. These effects did not increase in severe hyperlipidemic blood from aged mice and upon 
feeding a high-fat diet (Apoe−/− mice). Bone marrow from wild-type or Ldlr−/− mice was transplanted 
into irradiated Ldlr−/− recipients. Markedly, thrombus formation was enhanced in blood from chimeric 
mice, suggesting that the hyperlipidemic environment altered the wild-type platelets, rather than the 
genetic modification. The platelet proteome revealed high similarity between the three genotypes, 
without clear indication for a common protein-based gain-of-function. The platelet lipidome revealed 
an altered lipid profile in mildly hyperlipidemic mice. In conclusion, in Apoe−/− and Ldlr−/− mice, modest 
elevation in plasma and platelet cholesterol increased platelet responsiveness in thrombus formation 
and ensuing fibrin formation, resulting in a prothrombotic phenotype.
Hyperlipidemia initiates, drives and aggravates atherosclerotic plaque formation, as an underlying cause for cardi-
ovascular  diseases1,2. In human adults, low plasma levels of cholesterol and triglycerides are highly  desirable3,4. In 
2015 however, 95 million adult Americans were presenting with elevated levels (> 200 mg/dl) of total  cholesterol5. 
Similarly, in Europe the high prevalence of high plasma cholesterol is a serious health  problem6. The relationship 
between hyperlipidemia, atherosclerosis and thrombosis has been extensively  investigated7,8. Already in 1975, it 
was suggested that hypercholesterolemia in monkeys predisposes to increased platelet  aggregation9. However, 
the majority of the studies investigating the effects of hyperlipidemia on atherothrombosis were performed in 
genetically modified mice, fed a high fat  diet10. Depending on the genotype—Apoe−/− or Ldlr−/−—feeding with 
a high fat diet causes plasma cholesterol and triglycerides levels increase to levels at least 5–tenfold higher than 
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observed in hyperlipidemic individuals (> > 240 mg/dL)11,12. These levels are well known to induce plaque for-
mation with ensuing atherothrombotic effects. However, much less is known about the effects of less aggressive 
forms of hyperlipidemia, that align with those seen in humans (mildly increased cholesterol levels of 200–239 mg/
dL), on the thrombosis propensity and platelet activation.
Next to absolute cholesterol levels, also lipoprotein profiles of mice are distinct from man, in whom cho-
lesterol is transported by low-density  lipoproteins12. The Apoe−/− mice carry plasma cholesterol in majority as 
very low-density lipoproteins and chylomicrons. The lipoprotein profile of Ldlr−/− mice resembles more that 
of human hypercholesterolemia, with cholesterol preferentially transported by low-density  lipoproteins12,13. 
Both knockouts develop progressive atherosclerosis of the aortic arch and carotid arteries, although the precise 
mechanism differs between the  genotypes10,14–17, in that atherosclerotic lesion formation upon LDLR deficiency 
more relies on the dietary fat  content11.
In the present study, we aimed to investigate how a moderate elevation of the plasma cholesterol influences 
platelet activation and thrombus formation. For this purpose, we adapted two multiparameter ex vivo methods 
of shear-dependent whole blood thrombus formation for murine blood, to study (1) platelet activation and 
aggregation at a collagen surface and (2) the kinetics of collagen/tissue factor (TF)-induced thrombus and fibrin 
clot formation. The mice were fed a normal chow diet, in order to provoke mildly increased plasma cholesterol 
levels in Apoe−/− and Ldlr−/− mice. We detected a platelet-dependent increase in thrombotic tendency using blood 
from both Apoe−/− and Ldlr−/− mice, compared with normocholesterolemic wild-type mice. These effects were 
not further aggravated in aged mice, nor in high-fat diet fed Apoe−/− mice with 50% higher plasma cholesterol 
levels. Exploration of the platelet proteome and lipidome revealed additional insight into the platelet factors 
contributing to this prothrombotic phenotype of platelets.
Results
Multi-parameter assessment of platelet prothrombotic phenotype under flow in Ldlr−/− and 
Apoe−/− mice. To investigate how platelet functions are modified under mildly hyperlipidemic conditions 
in both Apoe−/− or Ldlr−/−  mice16,18, we adapted a previously validated multiparameter test for the simultaneous 
assessment of platelet adhesion and activation in human  blood19. Accordingly, using microfluidics, recalcified 
whole blood from wild-type, Apoe−/− and Ldlr−/− mice of 9–12 weeks old, held on normal chow diet, was perfused 
over collagen micro-spots. Analysis of the platelet deposition on collagen did not show differences in adhesion 
between the genotypes (Fig.  1A,Bi). However, the thrombi that were generated with blood from Apoe−/− or 
Ldlr−/− mice appeared denser in structure and more layered compared to the wild-type mice (Fig.  1A). The 
difference was also seen as an increased thrombus contraction and aggregate multilayer score (Fig. 1C, see P3 
and P4). In addition, specific platelet activation markers (PS exposure, P-selectin expression and integrin αIIbβ3 
activation) were increased for the Ldlr−/− mice, compared to wild-types (Fig. 1B). However, for Apoe−/− mice, PS 
exposure remained unchanged, and other activation markers were slightly reduced (Fig. 1Bi).
To investigate whether the thrombus-forming process was influenced by the (lipid) composition of the blood, 
blood samples were analyzed from both young and aged wild-type, Apoe−/− and Ldlr−/− mice. Overall, similar gen-
otype-induced differences were observed for platelet adhesion and activation parameters for the aged animals as 
compared to the young mice (Fig. 1Bii, suppl. Figure 1A). Hematological parameters indicated a 35% lower plate-
let count in blood from all Ldlr−/− mice, but not Apoe−/− mice, compared to wild-types (Suppl. Table 1). Across 
mouse strains, platelet count increased by 25–45% upon ageing, in agreement with published  findings20. Red and 
white blood cell counts were similar between genotypes and age groups. It has been reported that Apoe−/− mice 
develop leukocytosis, especially when receiving a high-fat  diet11. In our study with mice on normal chow diet, 
numbers of leukocytes were similar in all genotypes (Suppl. Table 1). However, in Apoe−/− mice that were held 
on high-fat diet (Suppl. Figure 2), we noted a significant increase in leukocyte counts from 3.8 ± 0.8 × 103/µl to 
Figure 1.  Multiparameter assessment of platelet activation and aggregation under arterial flow of Apoe−/− and 
Ldlr−/− mouse blood in the absence of coagulation. Blood was used from young (9–12 weeks) and aged (37–
42 weeks) Apoe−/−, Ldlr−/− and corresponding wild-type mice, held on normal chow diet. PPACK-anticoagulated 
blood was perfused over collagen type I at wall shear rate of 1000 s−1. Brightfield images were captured, after 
which the deposited platelets were stained for integrin αIIbβ3 activation, P-selectin expression and PS exposure 
in different colors (see “Methods”). (A) Representative images from young mice are shown for each color per 
genotype. Bars indicate 20 μm. (B) Quantification (% SAC) of brightfield images of platelet deposition and 
fluorescence images of platelet activation parameters: phosphatidylserine (PS) exposure, P-selectin expression 
and integrin αIIbβ3 activation of (i) young mice and (ii) aged mice. Mean ± SEM (n = 6–15 animals/group). 
*P < 0.05, **P < 0.01 and ***P < 0.001 vs. wild-type (Mann–Whitney U test). (C) Platelet activation parameters 
were obtained from brightfield and fluorescence images after 3.5 min: P1, morphological score; P2, platelet 
surface area coverage (% SAC); P3, aggregate contraction score; P4, aggregate multilayer score; P5, aggregate 
multilayer coverage (% SAC); P6, PS exposure (% SAC); P7, P-selectin expression (% SAC); P8, integrin αIIbβ3 
activation (% SAC). Values per parameter were linearly scaled to 0–10 and a scaled heatmap with integration 
of age groups was generated. (D) Scaled heatmap of effect sizes per genotype. Effect size per parameter was 
calculated from the pooled standard deviation, Cohen’s d and regression coefficient r. Analysis based on relevant 
changes restricted to differences with P < 0.05 (t test, 2-sided, equal variance). Means (n = 15–20 animals/group). 
(E) Isolated platelets were activated by thrombin (0.5–4 nM) or cross-linked collagen-related peptide (CRP-XL, 
0.5–5 μg/ml); exposure of phosphatidylserine (PS), P-selectin and activation of integrin αIIbβ3 were determined 
by flow cytometry using AF647-labeled annexin A5, FITC-labeled anti-CD62P mAb, and PE-labeled JON/A 
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6.1 ± 2.4 × 103/µl (mean ± SD, n = 10–12, P < 0.01). In comparison to wild-type mice, plasma cholesterol levels 
were more elevated in aged Apoe−/− mice (sixfold) than in aged Ldlr−/− mice (threefold) (Suppl. Table 1).
A heatmap was generated for a more systematic analysis of the eight thrombus parameters, which were aver-
aged and scaled per parameter (Suppl. Figure 1B). Statistical analysis indicated that only 1 out of 8 parameters 
differed between the age groups of Ldlr−/− mice, and that none of the parameters differed between the young 
and old Apoe−/− mice. This allowed us to pool the values from either age group per genotype (Fig. 1C). The 
effect-size differential heatmap of Fig. 1D, obtained by filtering differences from wild-types against significance 
(P < 0.05), then pointed to a clear prothrombotic phenotype of the blood from both knockout mice, albeit with 
a different pattern of increased parameters. The Apoe−/− mice showed predominantly increased platelet aggre-
gation parameters (morphological score, multilayer score and platelet aggregate coverage) (Fig. 1D); while the 
Ldlr−/− mice showed elevated platelet aggregation as well as activation markers (PS exposure, P-selectin expres-
sion and integrin activation).
Flow cytometry analysis with isolated platelets confirmed that platelet activation was increased upon GPVI 
stimulation, when comparing the knockouts with wild-types (Fig. 1E). In an additional study, Apoe−/− mice were 
fed a high fat diet, increasing plasma cholesterol by 50% (Suppl. Figure 2A). Markedly, this diet did not further 
increase the prothrombotic phenotype upon ApoE deficiency, as detected by either microfluidics tests or flow 
cytometry of platelet activation with a panel of agonists (Suppl. Figure 2B,C). Given that flow perfusion over 
collagen is a relevant surface for identifying changes in murine arterial  thrombosis21,22, we concluded that the 
platelets from both Apoe−/− and Ldlr−/− mice carry a prothrombotic phenotype, with Apoe−/− platelets showing 
predominantly an increased aggregation tendency and Ldlr−/− platelets showing an increased secretion.
Enhanced platelet-dependent fibrin and thrombus formation under flow in Ldlr−/− and Apoe−/− 
mice. To investigate whether the increased platelet responses of Apoe−/− and Ldlr−/− mice extended to coagu-
lation stimulation, i.e. fibrin formation, we adapted a method to assess the kinetics of this process using perfused 
human  blood23. Therefore, recalcified mouse blood was labeled with  DiOC6 and AF647-fibrinogen, and per-
fused through a flow chamber over two microspots consisting of collagen type I (upstream microspot Ma) and 
collagen type I + TF (downstream microspot Mb).
Whole blood flow under coagulating conditions resulted in similar platelet deposition for all three genotypes 
on collagen/TF (Fig. 2A,Bi), although a slight but significant decrease in platelet deposition was observed for aged 
Ldlr−/− mice compared to the corresponding wild-types (Fig. 2Bii). Using blood from young or aged wild-type 
mice, the co-coating of TF significantly enhanced platelet deposition on collagen (Fig. 2B vs. Suppl. Figure 4B, 
P < 0.001). With blood from Apoe−/− or Ldlr−/− mice, platelet deposition in the absence of TF was enhanced after 
4–6 min, when compared to wild-types (Suppl. Figure 4A, D), while TF did not further enhance this parameter 
(Fig. 2B). Accordingly, in contrast to wild-type blood, there was measurable fibrin formation in the absence of 
TF with blood from Apoe−/− or Ldlr−/− mice (Fig. 2B, Suppl. Figure 4C). At the TF-containing spot Mb, 2–3 times 
more fibrin was formed when using blood from Apoe−/− or Ldlr−/− mice than with wild-type blood (Fig. 2A,B). In 
agreement with this, the time to fibrin formation was shortened in blood from either knockout mouse (Fig. 2B). 
Of note, in the absence of TF, no fibrin was formed in wild-type mice within 10 min, while in all young and aged 
knockout mice fibrin was generated within 10 min (Fig. 2B). No differences were recorded between young or 
old mice, regardless of the genotype (Fig. 2, Suppl. Figures 3 and 4). Kinetic analysis of platelet deposition in the 
presence of TF did not reveal differences between genotypes or age groups, while fibrin deposition in time was 
markedly enhanced for both Apoe−/− and Ldlr−/− mice compared to wild-type mice (Suppl. Figure 3B). To deter-
mine the rate of fibrin formation, the slope of each curve was calculated over the steepest part (1.5–3.75 min). For 
wild-type blood, the maximum slope was 4.8%SAC/min. For Apoe−/− blood, this slope increased to 8.5%SAC/min 
(P < 0.05 vs. wild-type). For Ldlr−/− mice this value further elevated to 13.4%SAC/min (P < 0.0005 vs. wild-type).
To allow a direct comparison of all differences in thrombus formation, a heatmap was generated using five 
outcome parameters (Pa-e), four of which were assessed at 0, 2, 4 and 6 min (Suppl. Figure 3C). Of the 34 
Figure 2.  Deficiency in ApoE or LDLR enhances formation of platelet–fibrin thrombi in the presence of 
coagulation at arterial flow rate. Blood was obtained from young (9–12 weeks) and aged (37–42 weeks) Apoe−/−, 
Ldlr−/− and corresponding wild-type mice held on normal chow diet. Citrated blood samples were supplemented 
with  DiOC6 (labeling platelets) plus AF647 fibrinogen, and co-perfused with  CaCl2/MgCl2 over two microspots 
consisting of collagen (microspot Ma) and collagen/TF (microspot Mb) at a wall shear rate of 1000 s−1. 
Confocal two-color fluorescence images were captured in real time at 45 s time intervals. (A) Representative 
images of deposited platelets  (DiOC6, green) and fibrin (AF647, red) from young mice at spot Mb after 4 min; 
bars = 20 µm. (B) Quantification of surface area coverage (% SAC) of platelet deposition, and fibrin-covered 
area at spot Mb after 4 min; horizontal dotted line indicates labeling threshold for fibrin formation, as well as 
quantification of time to first fibrin formation of (i) young mice and (ii) aged mice. Left part: whole blood was 
perfused over collagen co-coated with tissue factor (+ TF), right part: Time to first fibrin formation in whole 
blood perfused over collagen without tissue factor (− TF). (C) Thrombus parameters were obtained from 
brightfield and fluorescence images at time points 0, 2, 4 and 6 min: Pa,  DiOC6 platelet deposition (% SAC); Pb, 
 DiOC6 platelet thrombus score (0–5); Pc, time to first fibrin formation (− log min); Pd, AF647 fibrin score; Pe, 
AF647 fibrin-covered area (% SAC). Values per parameter were linearly scaled to 0–10. Presented is a scaled 
heatmap of the integrated age groups (9–12 weeks and 37–42 weeks, see suppl. Figure 3). (D) Scaled heatmap 
of changes per genotype, filtered for moderate effect size. Effect size per parameter was calculated from pooled 
standard deviation, Cohen’s d and regression coefficient r. Analysis based on relevant changes restricted to 
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obtained parameters of thrombus formation on two microspots, only 2–8 parameters showed significant dif-
ferences between the mouse age groups of all genotypes (Suppl. Figure 3C). In agreement with previous  data24, 
the various parameters per microspot were mostly correlated when examined per genotype (Fig. 2C). When 
comparing the knockout strains, gain-of-function values (represented as yellow–red coloring) were observed 
for both the Apoe−/− and Ldlr−/− mice, when compared to corresponding wild-types, especially for the fibrin 
parameters Pc, Pd and Pe.
A subtraction heatmap was created for better visualize of differences in terms of effect sizes per parameter 
(Fig. 2D). This revealed a similar prothrombotic phenotype in phosphatidylserine exposure and fibrin forma-
tion for both Apoe−/− and Ldlr−/− mice, especially in the presence of TF. This extended analysis hence suggested 
that the hyperlipidemic condition in either knockout strain led to an increase in platelet activation and ensuing 
fibrin formation under flow conditions.
To investigate if coagulation processes were altered, platelet-free plasma from the genotypes was analyzed 
for the presence of thrombin-anti-thrombin (TAT) complexes, as a sensitive marker of ongoing thrombin gen-
eration in  vivo25. No significant differences between the three strains were seen (Fig. 3A). The TF-induced 
thrombin generation test in plasma showed a slightly increased endogenous thrombin potential for Apoe−/−, 
compared to wild-type or Ldlr−/− plasma (Fig. 3B). This pointed to a weak enhancement of coagulant activity in 
only Apoe−/− mice, which however cannot fully explain the increased platelet-dependent fibrin formation during 
perfusion of whole blood from both Apoe−/− and Ldlr−/− mice.
When relating per genotype the plasma cholesterol levels (Suppl. Table 1) with the extent of PS exposure 
in isolated platelets (Fig. 1E), there appeared to be a good correlation (Fig. 4A). Furthermore, this correlation 
extended to the amounts of fibrin formed (Fig. 4B). Although correlational, this analysis suggested a role of 
plasma cholesterol in the mildly hyperlipidemic mice in determining platelet-dependent coagulation.
Hyperlipidemic environment promotes gain-of-platelet-function. To provide more direct evi-
dence for the influence of plasma cholesterol on platelets in these mice, we then performed a transplantation 
study. Bone marrow obtained from either wild-type or Ldlr−/− donor mice was injected into whole-body irradi-
ated Ldlr−/− recipient mice, and the mouse blood samples were analyzed at 6 weeks after transplantation. Repop-
ulation of the bone marrow with transplanted cells was confirmed in DNA extracted from white blood cells 
(92 ± 2% LDLR chimerism). In addition, plasma cholesterol levels were checked, and appeared to be equally 
high in both groups (Suppl. Table 2). Flow cytometry analysis of the blood samples demonstrated a similar, high 
Figure 3.  No relevant differences in coagulation parameters measured in plasma from Apoe−/− and Ldlr−/− 
mice. (A) Circulating thrombin-antithrombin (TAT) complexes measured in plasma from wild-type, Apoe−/− 
and Ldlr−/− mice on normal chow diet. Means ± SEM (n = 5–6 animals/group, Mann–Whitney U test). (B) 
Thrombin generation in plasma from Apoe−/− and Ldlr−/− mice. Calibrated automated thrombin generation was 
assessed at 1 pM tissue factor (f.c.) in platelet-free plasma from wild-type, Apoe−/− and Ldlr−/− mice. Standard 
curve parameters were recorded: shown is endogenous thrombin potential (ETP, area-under-the-curve) as 
means ± SEM (n = 6–8). **P < 0.01 vs. wild-type (Mann–Whitney U test). Lag time to initial thrombin, thrombin 
peak height, and time-to-thrombin peak were not significantly different between groups (not shown).
Figure 4.  Plasma cholesterol level is associated with platelet phosphatidylserine exposure and platelet-induced 
fibrin formation. Plasma cholesterol level (Table 1) from wild-type, Apoe−/− and Ldlr−/− mice plotted against: (A) 
exposure of phosphatidylserine (PS) in washed platelets stimulated with 5 mg/ml CRP-XL (see Fig. 1E) and (B) 
surface area coverage (% SAC) of fibrin-covered area from whole blood perfusion over collagen/TF (Fig. 2B).
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platelet activation tendency of the WTBM and Ldlr−/−BM platelets (Fig. 5A). Flow perfusion experiments on col-
lagen I indicated a similar gain-of-platelet-function for both transplantation arms, i.e. similar to the blood from 
full Ldlr−/−mice, when compared to wild-type blood (Fig. 5B). This provided a clear indication that the hyper-
lipidemic environment in the recipient Ldlr−/− mice provoked a gain-of-platelet function of wild-type platelets, 
to reach the prothrombic activity of Ldlr−/− platelets.
Minor common changes in proteome of platelets from Ldlr−/− and Apoe−/− mice. Using quanti-
tative proteomics analysis, we explored the protein composition of Apoe−/− and Ldlr−/− platelets in comparison 
to wild-type platelets. From platelet samples of all genotypes, ratio information was obtained regarding 1,533 
unique proteins. Volcano plots indicated differences in ratios for multiple identified proteins between wild-type 
and Apoe−/− or Ldlr−/− platelets (Fig. 6A). Statistics after correction for multiple testing pointed to 655 and 21 
significant protein changes in the Apoe−/− and Ldlr−/− platelets, respectively. Of these proteins, only a few showed 
relevant changes, i.e. > 1.5-fold as previously  defined26,27. For Apoe−/− platelets this concerned 277 proteins (18%), 
and for Ldlr−/− platelet 9 proteins (0.6%) (Fig. 6B and Suppl. Table 3). Remarkably, only 4 proteins were jointly 
upregulated and none were jointly downregulated in both knockout strains (Suppl. Table 3C).
Regarding cellular functions of the altered  proteins28,29, these were confined to mostly structural proteins 
(Table 1). For Apoe−/− mice downregulation was observed in several mitochondrial and metabolic proteins, 
while both up- and downregulation was seen of in particular reticular, membrane and signaling-related proteins. 
Specifically, in Ldlr−/− platelets, secretory proteins were upregulated compared to wild-type platelets. However, 
close inspection of the (moderately) altered proteins did not reveal candidates for a common increase in platelet 
activation tendency for the two hyperlipidemic mouse strains.
Figure 5.  Similar activation of wild-type and Ldlr deficient platelets after transplantation of Ldlr-deficient mice. 
Bone marrow transplantations were performed using bone marrow from either wild-type (WTBM) or Ldlr−/− 
mice (Ldlr−/−BM) injected into irradiated Ldlr−/− recipients, held on normal chow diet. (A) Isolated platelets 
were activated by thrombin (0.5–4 nM) or cross-linked collagen-related peptide (CRP-XL, 0.5–5 μg/ml), and 
exposure of PS, P-selectin and activation of integrin αIIbβ3 were determined by flow cytometry using AF647-
labeled annexin A5, FITC-labeled anti-CD62P mAb, or PE-labeled JON/A mAb, respectively. Means ± SEM 
(n = 4–8 animals/group). (B) PPACK-anticoagulated blood was perfused over collagen type I at wall shear 
rate of 1000 s−1. Brightfield images were captured, after which the deposited platelets were stained for integrin 
αIIbβ3 activation, P-selectin expression and PS exposure in different colors. Platelet activation parameters were 
obtained, as described for Fig. 1. Left: Scaled heatmap with integration of age groups. Right: Scaled heatmap of 
effect sizes per genotype. Effect size per parameter was calculated from the pooled standard deviation, Cohen’s d 
and regression coefficient r. 
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Changes in platelet lipid profiles of ApoE and LDLR deficient mice. Given the common, moder-
ate hyperlipidemic phenotype of both mouse strains (Suppl. Table 1), we also assessed the lipidomic profiles of 
Apoe−/−, Ldlr−/− and wild-type platelets. Quantitative analysis of the lipid classes indicated that especially free 
cholesterol and cholesteryl esters were elevated in platelets from Apoe−/− as well as Ldlr−/− mice (Fig. 7A,B). Addi-
tional differences in comparison to wild-type platelets were observed for specific sphingolipids. The sphingolipid 
precursor ceramide was significantly increased in Apoe−/− platelets (Fig. 7C). Ceramide incorporates into sphin-
gosine and sphingosine-1-phosphate in the endoplasmic  reticulum30, and both were also increased in Apoe−/− 
platelets (Fig. 7D,E). In contrast, the level of sphingosine was downregulated in Ldlr−/− platelets (Fig. 7D). Cera-
mide is also transported to the Golgi system, where the glycosphingolipids isoforms HexCer and Hex2Cer are 
 formed30. Both isoforms were also significantly increased in Apoe−/− platelets, but less so in Ldlr−/− platelets 
(Fig. 7F,G). No differences were observed for other sphingolipids (Fig. 7H,I). Cluster analysis of the quantitative 
lipidome analysis highlighted the changes in lipid classes between the three genotype groups (Fig. 7J).
Discussion
In this paper, we investigated the prothrombotic propensity and underlying processes of two (moderately) hyper-
lipidemic mouse strains, i.e. Apoe−/− and Ldlr−/− mice, fed a normal chow diet. Multiparameter measurements of 
whole blood thrombus and fibrin formation on collagen indicated an exacerbation of the thrombotic process in 
either knockout strain, when compared to the corresponding wild-type mice. These altered platelet properties 
were not further aggravated in aged mice, nor by a high-fat diet (Apoe−/−), i.e. conditions that further elevate 
the plasma cholesterol levels by 50%. This suggested that a moderate elevation in plasma cholesterol is sufficient 
to enhance platelet activation and ensuing fibrin formation. Thrombin generation curves and TAT complexes 
in plasma did not show differences between genotypes, except for a moderate increase in thrombin potential 
in Apoe−/− mice, suggesting that the observed effects are primarily due to changes in the platelets themselves. 
Importantly, bone marrow transplantation of wild-type or Ldlr−/− platelets into irradiated Ldlr−/− recipient mice 
resulted in platelets with a similar gain-of-function in adhesion, activation and thrombus formation, indicat-
ing that the hyperlipidemic environment of Ldlr−/− mice led to an overall increased activation tendency of the 
chimeric wild-type platelets. Exploration of the platelet proteome revealed overall high similarity between the 
three genotypes, although some proteins showed significantly increased or decreased expression, particularly 
Figure 6.  Deficiency in ApoE or LDLR results in limited changes in platelet proteome. Highly purified platelets 
from wild-type, Apoe−/− and Ldlr−/− mice were used for quantitative proteome analysis after shot-gun proteolysis. 
Ratios of 1,533 unique proteins were quantified by label-free proteomics analysis. (A) Median peptide ratios 
per protein were log2 transformed and plotted as a function of − log10 P values. Depicted are volcano plots 
comparing platelets from (A) Apoe−/− with corresponding wild-type mice, and (B) Ldlr−/− with wild-type mice. 
Dotted line indicates P = 0.05 (t test). (C) Venn diagram of number of proteins with a > 1.5-fold down- (green) or 
upregulation (red) in platelets from Apoe−/− and Ldlr−/− mice, as compared to wild-types.
9
Vol.:(0123456789)
Scientific Reports |        (2020) 10:21407  | https://doi.org/10.1038/s41598-020-78522-9
www.nature.com/scientificreports/
in Apoe−/− mice. Finally, platelets of the mildly hyperlipidemic mice had an altered lipid profile, which is likely 
to play a role in the observed prothrombotic phenotype.
In the absence of coagulation, both knockout mice demonstrated a prothrombotic phenotype in whole blood 
perfusion over collagen, but with a different pattern of increased parameters. In comparison to wild-types, 
Apoe−/− platelets showed predominantly an increased aggregation tendency and Ldlr−/− platelets showed increased 
secretion. Multiparameter measurements of thrombus formation on collagen/TF in the presence of coagulation 
indicated a strikingly similar enhancement of the thrombotic process in both knockout mice. This agrees with 
reports that both mouse strains display an aggravated arterial thrombosis tendency in  vivo16,18. Remarkably, the 
enhancement was also seen on collagen microspots in the absence of TF, which indicates that the prothrombotic 
phenotype (both coagulation and platelets) has already reached a plateau, and is not further enhanced by TF. 
This agrees with a platelet-dependent rather than a TF-triggered mechanism of the prothrombotic propensity. 
Indeed, collagen has been established as a key component of (ruptured) atherosclerotic plaques driving arterial 
thrombosis in vivo and in  vitro31,32. In addition, the observed increases in platelet activation may stimulate platelet 
adhesion to other components of the inflamed vessel wall at atherosclerotic  plaques33.
In the blood from aged Ldlr−/− mice, we observed a minor 6% reduction in platelet deposition on collagen, 
which related to a 35% lower platelet count (unchanged platelet volume) in these mice, when compared to wild-
types. This reduction in platelets was unexpected, since other studies suggest that platelet production is promoted 
by hypercholesterolemia (reviewed by Wang et al.34). Normal values of murine platelet counts in the literature 
vary between 450 to 1690 × 109/L35. Given this, the count in all three genotypes was within the normal range. 
Furthermore, the moderate platelet reduction in Ldlr−/− does not seem of physiological relevance, since in mouse 
an 80% reduction in count is needed to affect in vivo arterial thrombus  formation36. No relevant differences 
in leukocyte count were observed, other than an increase in Apoe−/− mice maintained on high-fat diet, which 
agrees with a previous  report11. Together, our findings are in support of the concept of reactive thrombopoiesis, 
meaning that megakaryocytes adapt to a changing (lipid) environment, thereby affecting the formed  platelets37,38.
Several studies have reported an enhanced arterial thrombosis tendency in  vivo in Apoe−/− and 
Ldlr−/−  mice16,18,39–41. As we recently demonstrated in a synthesis paper, analyzing over 1400 studies with geneti-
cally modified mice, gene deletion effects on thrombus formation in vitro appeared to correlate significantly 
with the gene deletion effects on arterial thrombosis in  vivo42. Accordingly, the current findings of a prothrom-
botic propensity in vitro of (platelets in) Apoe−/− and Ldlr−/− blood are fully in line with the earlier detected 
enhanced thrombosis in these mouse strains. Yet, in translational terms, a limitation of the present study is that 
Apoe−/− and Ldlr−/− mice are still genetic in nature and have a lipid profile that differs from the human  situation12. 
Table 1.  Overview of differences in quantitative proteome of ApoE- and LDLR-deficient platelets as compared 
to wild-type platelets. Highly purified platelets from wild-type, Apoe−/− and Ldlr−/− mice were subjected to 
label-free proteomics analysis. Ratios of 1,533 unique proteins were quantified by mass spectrometry (see 
“Methods”). Unique proteins of the quantitative proteome were assigned to 22 assumed function classes. Green 
represents > 1.5 fold downregulated and red > 1.5-fold upregulated proteins. N = 3–4 animals/group.
Assumed funcon class
Down Up Down Up
1 Cytoskeleton acn-myosin 8 2 0 0
2 Cytoskeleton intermediate 0 0 0 0
3 Cytoskeleton microtubule 2 7 0 0
4 Cytoskeleton receptor-l inked 1 2 0 0
5 Endosome proteins 2 1 0 0
6 ER & Golgi proteins 8 12 0 0
7 Glucose metabolism 3 0 0 0
8 Lysosome & peroxisome proteins 2 1 0 0
9 Membrane & protein trafficking 6 8 0 0
10 Membrane receptors & channels 4 10 0 2
11 Mitochondrial proteins 27 2 0 1
12 Other metabolism 21 5 0 0
13 Other nuclear proteins 3 3 0 0
00301emosaetorP41
15 Protein kinases & phosphatases 5 5 0 0
16 Protein processing 4 0 0 0
17 Secretory proteins 6 8 0 4
18 Signall ing & adapter proteins 19 18 0 0
19 Small  GTPases & regulators 11 8 0 0
20 Transcripon & translaon 13 9 0 0
21 Unknown & other platelet proteins 5 6 0 0
22 Extracellular plasma proteins 0 6 0 2
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Although murine platelets differ from human platelets with regard to size, and number, functionally they are very 
 similar35,43. Furthermore, the interplay of platelet activation and coagulation appears to be remarkably similar 
between mouse and  man35,42,44. Feeding of wild-type mice with a high-fat diet may be a more physiologically 
Figure 7.  Alterations in lipid profile in platelets from Apoe−/− and Ldlr−/− mice. Highly purified platelets from 
wild-type, Apoe−/− and Ldlr−/− mice were used for quantitative lipidomic analysis. (A) Cholesterol and (B) 
cholesteryl esters (ChoE); (C) ceramides (Cer); (D) sphingosine (So); E) sphingosine-1-phosphate (S1P); F) 
glycosylceramide or galactosylceramide (HexCer); (G) lactosylceramide (Hex2Cer); (H) Sphingomyelin (SM); 
(I) sphinganine (Sa). Means ± SEM (n = 4–6 animals/group), *P < 0.05, **P < 0.01, ***P < 0.001 (Mann–Whitney 
U test). (J) Cluster analysis of quantitative lipidome analysis. Significantly altered lipid classes of Apoe−/− or 
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relevant model, although also wild-type mice have a dissimilar lipid profile as compared to humans. Few stud-
ies have shown that also in wild-type animals, feeding a high-fat diet results in a prothrombotic phenotype and 
altered coagulation  profile45–48. Yet, a translation from mouse studies to the human situation should be treated 
with caution.
The more enhanced fibrin-thrombus formation of Apoe−/− mice was accompanied by a limited enhancement 
of coagulant activity in plasma from these mice. Given the earlier detected alterations in coagulation factor lev-
els in APOE2 knock-in  mice49, similar changes may be present in the current mouse strain, thus explaining the 
enhanced thrombin generation potential. Markedly, no alterations in plasmatic coagulation were observed in 
Ldlr−/−  mice11. However, viscosity and osmolality changes may also contribute to the plasma sensing of platelets 
in flow studies.
In mouse, hyperlipidemia has been linked to an increased platelet reactivity with proposed roles of oxidized 
LDL and of the receptor proteins, CD36 and  P2Y1216,50–52. The present comparison of the platelet proteome 
of (mildly hyperlipidemic) Apoe−/− and Ldlr−/− mice provides an extension of the first published platelet pro-
teome of wild-type (C57BL/6)  platelets53. Using a > 1.5-fold change as criterium for altered protein abundance 
 levels26,27, some proteins appeared to be up- or downregulated in the knockout platelets, with the changes in 
Apoe−/−  >  > Ldlr−/−. Changes were mostly confined to Golgi, membrane, signaling and secretory proteins. Regard-
ing the latter class, abundance levels of thrombospondin-2 and complement factors C3 and C4 were upregulated 
in platelets both knockout mice, while also coagulation factor XIII, reticulon-4, and amyloid beta protein were 
significantly changed in the Apoe−/− mice. By themselves, these proteins have been shown to influence platelet 
function as shown in several functional assays, including those used in the present study (Suppl. Table 4 and 
references therein). How these proteins in combination alter platelet function is unclear. Of special interest are the 
complement factors, as these are relevant in thrombo-inflammation54, as well as for platelet properties and shed-
ding of microparticles (Suppl. Table 4 and references therein). A recent study showed that  C3−/− mice displayed a 
prolonged bleeding time, and reduced thrombus formation, fibrin and platelet deposition in the ligated inferior 
vena cava, and diminished platelet activation in vitro55. Furthermore, the binding of C3 to platelets promotes 
the formation of platelet-leukocyte  aggregates54.
A major outcome of the platelet lipidome profiling was an increase in cholesterol species in both knock-
out mice. In translational terms, this matches with the high cholesterol levels in platelets from patients with 
 hypercholesterolemia56. Especially this finding is compatible with a prothrombotic phenotype, as this suggests 
alterations in membrane fluidity and an increase in membrane lipid rafts in the Apoe−/− and Ldlr−/−  platelets34. 
Platelet signaling is indeed considered to be dependent on membrane raft  formation57,58. Another difference in 
Apoe−/− and Ldlr−/− platelets compared to wild-types were (distinct) changes in levels of (glyco)sphingolipids. 
While an altered sphingolipid metabolism can modulate platelet  activation59, precisely how is still unclear. 
Options in the current context are effects of sphingolipid species on lipid sorting in the Golgi apparatus, or effects 
on lipid degradation in the lysosomes.
Hyperlipidemia is associated with shortened platelet survival and increased turnover in  man34 and  mouse37. 
However, our bone marrow transplantation experiment, in combination with only minor changes in the total 
platelet proteome, suggests that altered platelet protein function, not platelet count, is a major factor in the 
prothrombotic effects of hyperlipidemia. These changes in protein activity can be caused by post-translational 
modifications (PTMs), which regulate protein activity and are also effective in platelets. These PTMs include 
phosphorylation, glycosylation, palmitoylation, ubiquitination and oxidative stress, all of which have been 
described to alter platelet proteins during hemostasis as well as in several diseases including  hyperlipidemia60. 
Although both hyperlipidemic mouse strains show a prothrombotic phenotype, we also observed differences 
between the Apoe−/− and Ldlr−/− platelets in several measurements, as indicated above. One explanation for this 
may be the different lipoprotein profiles of Apoe−/− and Ldlr−/− mice, being mainly VLDL and chylomicrons par-
ticles or LDL,  respectively12. The effects of (oxidized) LDL on platelet function has been well  established61, and 
also some studies have shown that VLDL induces platelet  aggregation62,63. As different classes of lipoproteins have 
been shown to differently affect (human) platelet activation, the dissimilar balance in lipoprotein classes between 
both knockout strains may also explain the observed subtle differences in platelet activation. Furthermore, we 
postulate that different PTMs may be induced by LDL and VLDL.
Taken together, we conclude that the prothrombotic phenotype of mouse platelets in a mildly hyperlipidemic 
environment is triggered by the lipid surroundings, resulting in moderate changes in lipid abundance levels. The 
positive priming of platelets in hyperlipidemia increases their responsiveness and enhances platelet-dependent 
coagulation and fibrin clot formation under flow. In a translational perspective, it will be important to extend 
the study to humans with moderately elevated cholesterol levels.
Methods
Animals. All animal work was approved by the Maastricht University Animal Ethics Committee and the 
animal experiments were performed conform the guidelines from Directive 2010/63/EU of the European Parlia-
ment on the protection of animals used for scientific purposes. Wild-type C57BL/6J, Apoe−/− and Ldlr−/− mice 
(Charles River, Sulzfeld, Germany) of the same genetic background were used in age groups of 9–12 (young) or 
37–42 (aged) weeks old. Male and female mice were included at random. Animals were socially housed in stand-
ard cages, exposed to a 12 h light/darkness cycle, and given ad libitum access to water and food. Where indicated, 
Apoe−/− mice (10 weeks old) were fed with normal chow diet or with a cholate-free, high-fat diet (Arie Blok Diet 
W, Woerden, The Netherlands), consisting of (w/w) cocoa butter (15%), cholesterol (0.25%), sucrose (40.5%), 
corn starch (10%), corn oil (1%), cellulose (5.95%), casein (20%), 50% choline chloride (2%), methionine (0.2%) 
and mineral mixture (5.1%) with a total fat content of 16%64,65. For bone marrow transplantation, 1 × 107 bone 
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marrow cells obtained from wild type C57BL/6 J or Ldlr−/− donor mice were injected into irradiated (2 × 6 Gy) 
Ldlr−/− recipient  mice64.
Blood collection and processing. Mice were anaesthetized by subcutaneous injection of 100 mg/kg body 
weight ketamine and 0.5 mg/kg body weight medetomidine. Blood was taken through retro-orbital puncture, 
with 9 volumes collected into one volume of 129 mM trisodium  citrate66, after which mice were euthanized by 
cervical dislocation. Where indicated, blood was collected into 300 µl PPACK/fragmin anticoagulant solution, 
containing saline, H-Phe-Pro-Arg chloromethyl ketone (PPACK, 40 μM), low molecular weight heparin (frag-
min, 40 U/ml, Pfizer, Capelle a/d IJssel, The Netherlands) and heparin (5 units/ml, Sigma-Aldrich, St. Louis MO, 
USA)67. For the preparation of washed platelets, blood was collected 6:1 (vol./vol.) into acid citrate-dextrose 
solution (ACD, 80 mM sodium citrate, 52 mM citric acid, 183 mM D-glucose). Hematological blood parameters 
were determined in citrated blood using a Sysmex blood analyzer (Europe, Norderstedt, Germany). Platelet-free 
plasma (citrated) was stored at − 80 °C for later assessment of lipids and coagulation parameters.
Real-time assessment of platelet–fibrin thrombus formation under flow. Our method to assess 
whole blood thrombus formation under coagulant conditions at defined wall shear  rate23, was extended to a mul-
tiparameter  assay24, and adapted for mouse blood. In brief, coverslips were coated with two separate surfaces. In 
the direction of flow: microspot Ma: collagen type I (2 μl, 50 μg/ml); and Mb: collagen type I + tissue factor (TF, 
2 μl, 500 pM). After blocking with Tyrode’s Hepes buffer pH 7.45 (5 mM Hepes, 136 NaCl, 2.7 mM KCl, 2 mM 
 MgCl2, 0.42  NaH2PO4, 1 mg/mL glucose, 5 units/mL heparin) containing 1% BSA, the coverslips were mounted 
onto a parallel-plate flow chamber with precisely defined dimensions (depth 50 μm, width 3 mm and length 
30 mm)19. Perfusion with recalcified citrated blood was performed until 6 min at a shear rate of 1000 s−1. Recal-
cification medium consisted of 63 mM  CaCl2 and 32 mM  MgCl2 in Tyrode’s Hepes buffer; mixing with the blood 
was via a flattened Y-shaped dual inlet  tube23. Before each experiment, blood samples (500 μl) were pre-labeled 
with  DiOC6 (0.5  μg/mL, AnaSpec, San Jose CA, USA) and Alexa Fluor (AF) 647-labeled human fibrinogen 
(10 μg/mL, Molecular Probes, Bleiswijk, The Netherlands). Fluorescence (confocal) microscopic images were 
captured in two or three colors at 45 s intervals, to evaluate kinetics.
Multiparameter assessment of platelet activation and aggregation under flow. Platelet adhe-
sion and aggregation in perfused whole blood was measured under non-coagulant conditions as  described19,24, 
but adapted for murine blood. Coverslips were coated with a microspot (0.5 µl) of collagen type I (100 µg/ml) 
and mounted onto a flow chamber, and perfused with PPACK/fragmin-anticoagulated blood for 3.5 min at a 
wall shear rate of 1000 s−1. Platelets were stained according to a stringent protocol by 2 min post-perfusion with 
Tyrode’s Hepes buffer pH 7.45 (5 mM Hepes, 136 NaCl, 2.7 mM KCl, 2 mM  MgCl2, 0.42  NaH2PO4, 2 mM  CaCl2, 
1 mg/mL glucose, 1 U/mL heparin, and 1 mg/mL BSA), supplemented with fluorescein isothiocyanate (FITC)-
labeled rat anti-mouse CD62P mAb (1:40, Emfret Analytics, Würzburg, Germany), phycoerythrin (PE) labeled 
rat anti-mouse JON/A mAb (1:20, Emfret Analytics), and AF647 labeled annexin A5 (1:200, Invitrogen Life 
Technologies, Carlsbad, CA, USA). Representative end-stage brightfield microscopic images were taken from 
each microspot during staining. After 2 min of stasis, remaining labels were washed away by perfusion with 
label-free Tyrode’s Hepes buffer, after which three representative end-stage fluorescence images were collected 
per microspot.
Real-time microscopic image collection and quantitative image analysis. Microscopic images 
(1360 × 1024 pixels, 142 × 107  μm, 8-bit) were recorded with an EVOS fluorescence microscope (Life Tech-
nologies, Carlsbad CA, USA), equipped with GFP, RFP and Cy5 LED cubes, and an Olympus 60 × oil-immer-
sion objective, basically as  described19. For specific kinetic measurements, confocal fluorescence images were 
recorded with a LSM7 Live line-scanning system from Carl Zeiss (Jena, Germany)23.
Brightfield images, collected under non-coagulating conditions, were analyzed for the following  parameters19: 
morphological score (P1, scale 0–5); percentage surface area coverage of deposited platelets (P2, % SAC), platelet 
aggregate contraction score (P3, scale 0–3), aggregate multilayer score (P4, scale 0–3), and aggregate multilayer 
coverage (P5, % SAC). Scores were compared against redefined standard images. Raw fluorescence images were 
analyzed for PS exposure (P6, % SAC), P-selectin expression (P7, % SAC) and integrin αIIbβ3 activation (P8, % 
SAC). Images were examined by several observers. Two-color fluorescence images, collected under coagulating 
conditions, were analyzed for  DiOC6 platelet deposition (Pa, % SAC);  DiOC6 platelet thrombus score (Pb, scale 
0–5); time to first fibrin formation (Pc, − log min); AF647 fibrin score (Pd, scale 0–3) and AF647 fibrin-covered 
area (Pe, % SAC).
Values of SAC from brightfield and fluorescence images were determined, using specific scripts in Fiji software 
(Laboratory for Optical and Computational Instrumentation, University of Wisconsin-Madison WI, USA). Pro-
cessing was as single color, gray images, either in 8-bit (brightfield) or in 24-bit (GFP, RFP or Cy5 fluorescence). 
Scripts opened series of one-color images using a loop. In each run, background illumination was corrected 
using a fast Fourier transform bandpass (FFTB) filter; this was followed by a threshold setting (with manual 
adjustment) and a surface area coverage measurement. For brightfield images, a series of Gray morphology 
conversions was applied to reduce striping and improve the detection (a diamond large-sized close, followed 
by a medium-sized circle close and a small circle-shaped dilate). The first step increased the pixels yet stronger 
in regions with many neighboring pixels, the second step rounded the shapes and additionally reduced straight 
lines, while the final step could be altered by user interface to match the overlap with unprocessed images. The 
FFTB filter sizes were selected to have minimal impact on the image structures, but flatten the background areas 
sufficiently for good analysis. For both brightfield and fluorescence channels, large structures were filtered down 
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to 60–200 pixels, as appropriate per channel. Small structures were not filtered down, as these contained details 
of structures of interest within the platelets.
Multiparameter data processing. For each flow run, parameter values from individual brightfield and 
fluorescence images were averaged to obtain one value per parameter per microspot. For the complete database 
of all runs, these values were linearly normalized to a scale from 0–10 per individual parameter. Gene effect heat-
maps were obtained by subtracting per parameter the normalized average wild type values from the normalized 
average values of Apoe−/− or Ldlr−/− mice. Differences compared to wildtype were considered statistically sig-
nificant with P < 0.05 (t test, 2-sided, equal variance) after correction for multiple comparisons, where required.
Effect sizes per parameter and genotype were calculated according to Cohen’s d: d = (x ͂1 − x ͂2)/s, in which the 
raw data per flow run were used to calculate the pooled standard deviation s, taking the equation: s = √(((n1-1) 
s12 + (n2-1) s22)/(n1 + n2-2)). Subsequently, regression coefficients r were determined by the equation r = d/√(d2 + a), 
in which a represents the correction factor if n1 ≠ n2, calculated by the equation: a = (n1 + n2)2/n1n268. Normalized 
average and effect size heatmaps were produced using the R package version 3.2.5 (www.r-proje ct.org).
Flow cytometry. Flow cytometry with washed mouse platelets was performed with an Accuri C6 flow 
cytometer (Becton Dickinson, Ann Arbor MI, USA), as  described67. Platelets (1 × 108/mL) suspended in Tyrode’s 
Hepes buffer pH 7.45 containing 2 mM  CaCl2 were stimulated with convulxin (25–100 ng/mL)69, cross-linked 
collagen related peptide (CRP-XL, 0.5–5.0 μg/mL), methyl-thio-ADP (Me-S-ADP, 0.25–10 µM; Hart Biologicals, 
Hartlepool, UK), or thrombin (0.5–4.0 nM; Kordia, Leiden, The Netherlands), without stirring. Unstimulated 
samples were used as controls. After 15 min incubation, α-granule secretion was detected with FITC-labeled 
anti-CD62P mAb (1:10, Emfret Analytics, Wurzburg, Germany), integrin αIIbβ3 activation with PE-labeled rat 
anti-mouse JON/A mAb (1:10, Emfret Analytics), and PS exposure with AF647-annexin A5 (1:200, Molecular 
Probes).
Plasma lipids and coagulant activity. Platelet-free plasma was obtained by double centrifugation and 
stored at − 80 °C, as described  before70. After thawing, plasma triglycerides were determined with a Triglycerides 
FS5 Ecoline kit from DiaSys (Diagnostic Systems, Holzheim, Germany); plasma cholesterol was measured with a 
Cholesterol FS10 kit from DiaSys. Thrombin-antithrombin (TAT) complexes in plasmas were measured with an 
Enzygnost TAT micro-kit from Siemens (Erlangen, Germany). Kits were used according to the manufacturer’s 
instructions.
Calibrated automated thrombin generation. Thrombin generation with platelet-free plasma was per-
formed using a 96 well plate-based assay, essentially following a published  method71. Briefly, 20 μL of murine 
plasma was mixed with 10 μL of pre-trigger medium containing 7 pM tissue factor (Dade Innovin, Siemens, the 
Hague, The Netherlands), 0.83 mg/mL BSA, and 60 μM phospholipid mixture (PS/PE/PC, 20/60/20, w/w/w) in 
25 mM Hepes plus 165 mM NaCl (pH 7.5). Mixtures were incubated at 37 °C for 7 min, and then supplemented 
with recalcification buffer containing chromogenic thrombin substrate or α2M-thrombin  calibrator71. Thrombin 
generation was immediately calculated per well using Thrombinoscope software (Maastricht, The Netherlands).
Preparation of highly purified platelets for proteomics or lipidomics. Sample preparation for pro-
teomic and lipidomic analysis was performed, as described for human  blood29, with adjustments for mouse 
blood to maximize purified platelet yield. In brief, platelets for proteomics were prepared from ACD-anticoagu-
lated blood from one animal in an Eppendorf tube, which was supplemented with EGTA (0.5 mM) and apyrase 
(0.2 U/mL). Platelets for lipidomic analysis were prepared from citrate-anticoagulated blood. After centrifuga-
tion at 264 g for 5 min, the platelet-rich plasma (PRP) with the top 30% of red blood cells was transferred to a 
new tube. PRP was obtained by centrifugation at 80 g for 6 min, and transferred to a new tube. After addition 
of 200 μL Tyrode’s Hepes buffer (137 mM NaCl, 2 mM KCl, 12 mM  NaHCO3, 0.3 mM  NaH2PO4, 5.5 mM glu-
cose, 5 mM Hepes, pH 7.4) to the remaining 30% red blood cells, a second lot of PRP was obtained by another 
centrifugation step as above. The combined PRP samples were supplemented with ACD and apyrase, and centri-
fuged at 720 g for 6 min. The pelleted platelets were carefully resuspended into an adequate volume of Tyrode’s 
Hepes buffer containing ACD (1:10) and apyrase (1 U/mL), leaving the red cell pellet untouched, transferred to 
a clean Eppendorf tube and centrifuged again. This procedure was repeated, if necessary, to remove residual red 
and white blood cells.
For proteomic analyses platelets were isolated from 4 wild-type, 4 Apoe−/− and 3 Ldlr−/− mice, and the final 
platelet pellet was resuspended in 150 µL Tyrode’s Hepes buffer. Purity of the platelet suspension was verified 
using a Sysmex blood analyzer and by microscopic analysis, and approved when contamination of red cells and 
leukocytes was < 1:15,000 and < 1:20,000, respectively, in agreement with previously published  data12. The pure 
platelet samples were lysed with lysis buffer 1:1 pH 7.8 (50 mM Tris, 1% SDS, 150 mM NaCl, 1 tablet PhosS-
top/7 mL; Roche, Basel, Switzerland) containing a mixture of protease and phosphatase inhibitors (10 mM 
sodium orthovanadate  (Na3VO4, Sigma-Aldrich, St. Louis MO, USA) 4 mM phenylmethylsulfonyl fluoride 
(ThermoFisher Scientific, Breda, The Netherlands), 20 μg/mL leupeptin (VWR, Amsterdam, The Netherlands), 
5 μg/mL pepstatin (VWR, Amsterdam, The Netherlands) and 4 mM EDTA). Lysed samples were immediately 
snapfrozen and stored at − 80 °C until use.
For lipidomic analysis the final platelet pellet and the supernatant were separated and immediately snapfrozen 
and stored at − 80 °C until usage for lipidomics analysis, which was performed basically as  described59. During 
the procedures, blank extractions were performed for all analysis to detect possible contamination which could 
lead to false positive identification. Platelets in the analyzed preparations were unstimulated, verified by the 
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low amounts of secreted 12-HETE (all samples below 400 pmol/mg protein) and thromboxane  B2 (all below 
45 pmol/mg protein).
Proteomic analysis. A label-free quantification analysis was performed with mouse platelet samples, as 
described  before29. In short, the protein concentration of well-purified platelet samples (277–1390 × 109/L) in 1% 
SDS lysis buffer was estimated using the Bicinchoninic acid assay kit (Pierce, Thermo-Fisher Scientific, Bremen, 
Germany). After equalizing protein concentration, proteins were reduced with dithiothreitol and free sulfhy-
dryl groups were alkylated with iodoacetamide. Subsequently, 20 µg of protein sample were processed using 
filter-aided sample preparation (FASP), with a 30 kDa molecular weight cut-off spin filter. Thus, digestion was 
conducted with 50 mM ammonium bicarbonate, 200 mM guanidinium hydrochloride and 2 mM CaCl2, pH 7.8 
in the presence of trypsin (1:20 w/w, sequencing grade trypsin Promega, Madison WI, USA) for 14 h at 37 °C. 
Trypsin digestion was monitored by monolithic reversed phase  HPLC72. For label free analysis 2 µg of peptide, 
were analyzed by nano LC–MS/MS in DDA mode using a U3000 nano-RSLC system online-coupled to an 
Orbitrap Lumos mass spectrometer. Thus, peptides were loaded onto a trap column (Acclaim PepMap 100 C18; 
100 μm × 2 cm) with 0.1% trifluoroacetic acid (TFA). Then, peptides were separated on the main column (Pep-
Map 100 C18; 75 μm × 50 cm), using a binary gradient ranging from 3–45% solvent B (84% acetonitrile, 0.1% 
formic acid) in 150 min at 60 °C and a flow rate of 250 nL/min. In the Lumos Orbitrap survey scans were acquired 
in the Orbitrap at resolution of 120,000 FWHM, with an AGC target of 2 × 105 and a maximum injection time of 
50 ms. Data dependent MS/MS was performed using Top speed parameter with 3 s cycle time of the most intense 
signals using monoisotopic peak determination and an intensity threshold of 5 × 103, a dynamic exclusion of 15 s 
and an isolation window of 1.2 m/z using the quadrupole. Thus, peptide fragments were acquired in the ion trap 
in rapid scan mode with a first fixed mass of 120 m/z after fragmentation by Higher collision induced dissocia-
tion with 30% normalized collision energy. Additionally, an automatic gain control target value of 2 × 103 and 
maximum injection time of 300 ms with Inject ion for all available parallelizable time were used.
For label free quantification the Progenesis LC–MS software version 4.1 from Nonlinear Dynamics (New-
castle upon Tyne, UK) was used. Consequently, MS raw data were aligned in automatic mode. Exported peak 
lists were searched using SearchGUI 3.3.3, Mascot 2.6 (Matrix Science), X! TANDEM Vengeance (2015.12.15.2) 
and MS-GF + Release (v2018.04.09), with a concatenated target/decoy version of the mouse Uniprot database 
(July 2015, containing 16,716 sequences). Data analysis was done using PeptideShaker 1.16.23 (http://code.googl 
e.com/p/pepti de-shake r/), in order to maximize number of identified peptides and proteins. The following search 
parameters were used: trypsin as protease with a maximum of two missed cleavages; carbamidomethylation of 
Cys (57.021464) as fixed and as variable modification oxidation of Met (15.994915), acetylation of protein N-term 
and acetylation of K (42.010565). MS and MS/MS tolerances were set to 10 ppm and 0.5 Da. In PeptideShaker, 
search results were combined and filtered at a FDR of 1% (high confidence filter) on the protein level prior to 
export and re-import into Progenesis. Peptide sequences containing pyro-Glu (derived from X!Tandem 2nd 
pass search), oxidized methionine and acetylation of lysine and protein N-terminal were omitted from further 
data analysis. Only proteins with at least two unique peptides were considered for quantification. The mass 
spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the  PRIDE73 part-
ner repository with the dataset identifier PXD020276. For comparison between platelets from both knockout 
against wild-type mice described common platelet contaminant  proteins53 were removed and raw values were 
normalized. After normalization, a log 2 ratio was calculated, as well as P values (t test). In total, 1,533 proteins 
were quantified and regulated proteins were defined as 1.5-fold up- or downregulated.
Statistics. Data are presented as means ± SEM. Comparisons between age, diet and mouse genotypes 
(knock-out compared to wild-type) were made using the Mann Whitney U-test or the Kruskal–Wallis test for 
continuous variables. As we have shown previously, the majority of parameters tended to correlate positively 
per microspot, suggesting a ’thrombus profile’ represented by multiple  parameters24. Therefore, datasets were 
compared using Pearson or Spearman correlation analysis, as  described24.
For proteomic analysis, a t-test was used after normalization to compare up-or downregulated proteins 
between wild-type and knock-out mice. As multiple hypotheses were tested simultaneously, we corrected for 
multiple testing and controlled the false discovery rate (FDR; 0.05) with the Benjamini–Hochberg procedure, 
which adapts to the amount of signal in the data. The statistical package for social science version 22 was used 
(SPSS 22, Chicago IL, USA), with a P value < 0.05 considered to be significant.
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